Trial Profile
A Real world study evaluating efficacy and tolerability of Dimethyl fumarate in patients with relapsing remitting Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 20 Nov 2016 New trial record